Spouses and partners should not read the LiBBY headline as approval to try cannabis at home. LiBBY, short for Life's End Benefits of cannaBidiol and tetrahYdrocannabinol, tested a supervised purified oil for agitation in late-stage, hospice-eligible dementia only. Agitation means restlessness, pacing, yelling, hitting, or resisting care in advanced illness. The trial focused on easing that distress during hospice care, not on memory, prevention, or brain health for caregivers.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What LiBBY Tested
- What the Safety Numbers Mean
- Why Early Concerns Are Different
- What to Do About Agitation Now
What LiBBY Tested
Researchers enrolled 120 hospice-eligible patients with dementia-related agitation in a multicenter, randomized, double-blind, placebo-controlled Phase 2 trial. The Alzheimer's Association lists its presentation on July 14, 2026, at AAIC London. Participants took a purified oral oil with 2 mg THC plus 100 mg CBD twice daily versus placebo for 12 weeks.
Staff gave half dose in week 1, then full dose in weeks 2 through 12 under supervision. Neuroscience News reports in its trial summary a 6.27-point larger drop on the Cohen-Mansfield Agitation Inventory than placebo at week 2. The gap grew to 8.23 points by week 12. The inventory is a clinician scale that rates restlessness, aggression, and other agitated behaviors.
What the Safety Numbers Mean
The Pennington Biomedical Research Center states in its trial update that overall adverse events were similar, 46.7% with treatment and 42.4% with placebo. Serious adverse events were higher with treatment, 23.3% versus 11.9%, but investigators judged none drug-related.
In hospice care, serious medical problems are common even without a new drug. A small 12-week Phase 2 study cannot separate drug effects from that background risk. That is why investigators call for larger confirmatory trials before wider use.
Why Early Concerns Are Different
Being Patient notes in its AAIC coverage the result applies only to late-stage, hospice-eligible patients. It did not test prevention, memory improvement, or use by spouses with early concerns.
Late-stage agitation and early forgetfulness involve different care goals and risks. What eases distress under hospice supervision may harm an independent adult who drives, works, or manages medicines.
What to Do About Agitation Now
SciTechDaily, via Georgetown University Medical Center, notes in its research report the proprietary purified oil differs substantially from dispensary or over-the-counter cannabis. Partners should not try home products for agitation. Bring sudden agitation to the care team the same day.
Pain, infection, dehydration, poor sleep, or a new drug can trigger it. A nurse can check causes and adjust the supervised care plan. Do not start, stop, or change cannabis, sleep aids, or sedatives on your own. Call the hospice nurse or geriatric clinic before changing any dose or product.
- Note when it started, what happened just before, and what calmed it.
- List all medicines, alcohol, sleep aids, and over-the-counter products.
- Ask what hospice or geriatric clinicians advise for this stage.
You Might Also Like
- LiBBY Trial Findings for Late-Stage Dementia Agitation in 2026: How Spouses and Partners Can Avoid Overreading the Headline
- AAIC 2026 p-tau217 Alzheimer’s Risk Prediction Research: How Spouses and Partners Can Avoid Overreading the Headline
- p-tau217 Findings a Decade Before Alzheimer’s Symptoms in 2026: How Spouses and Partners Can Avoid Overreading the Headline
